FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone…
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.
What to keep in mind
This summary uses the publisher's own description. Read the original source for full details and context.
Joi Frontier Health News shares hopeful, credible health information. It is not medical advice, diagnosis, or treatment — talk with a qualified healthcare professional about your situation. If you are in crisis or thinking about self-harm, contact your local emergency or crisis line.
Comments
Comments here come from JoiApp readers.